Darlene Dobkowski, MA

June 03, 2023

Treating patients with metastatic castration-resistant prostate cancer with radium-223 also allowed patients to receive subsequent therapies such as chemotherapy.

May 31, 2023

Lynparza plus abiraterone was approved by the FDA for the treatment of patients with deleterious or suspected BRCA-mutated metastatic castration-resistant prostate cancer.

May 31, 2023

The agency accepted a New Drug Application for repotrectinib, a TKI for the treatment of patients with locally advanced or metastatic non-small cell lung cancer.

May 31, 2023

Some symptoms of myeloproliferative neoplasms are “pretty broad,” highlighting the importance of open communication with cancer teams to manage the symptoms and improve quality of life.

May 30, 2023

Women with hormone receptor-positive breast cancer who temporarily interrupted endocrine therapy for pregnancy had a similar recurrence rate to those from a control group, but one expert said that stopping therapy for a short time is still an important decision.

May 30, 2023

The approval of Posluma will help clinicians determine the extent of disease in men with prostate cancer and possible management options.

May 26, 2023

States that expanded Medicaid had improved survival rates in patients with pancreatic and gastric cancers, with greater improvements in Black patients for some analyses.

May 25, 2023

Patients born outside of the U.S. may have improved liver cancer survival rates compared with U.S.-born patients, although more research is needed to determine what may be driving this effect, research showed.

May 24, 2023

Many cancer centers and nonprofit organizations offer resources for patients with cancer and their caregivers to see the support they need to navigate diagnosis, treatment and survivorship.

May 22, 2023

The costs related to a cancer diagnosis go beyond treatment, reflecting the altered participation in the workforce for adolescents and young adults.

May 19, 2023

The FDA approval of Epkinly also includes a subset of patients with indolent lymphoma-related DLBCL and those with high-grade B-cell lymphoma after two or more systemic therapies.

May 18, 2023

Tagrisso plus chemotherapy improved progression-free survival in patients with EGFR-mutated, locally advanced or metastatic non-small cell lung cancer, according to high-level results from a phase 3 trial.

May 17, 2023

Patients with pancreatic cancer are treated with chemotherapy and surgery, depending on the stage, but more options are needed to treat a disease does not often respond to treatment.

May 16, 2023

Watch Dr. Percy Lee, from City of Hope, discuss radiation advances during the CURE® Educated Patient® Lung Cancer Summit.

May 15, 2023

One expert discussed the importance of understanding the different stages of pancreatic cancer and why the disease may be often diagnosed in later stages.

May 15, 2023

Watch Dr. Thomas Waddington, from City of Hope National Medical Center, discuss the past and future of bronchoscopy during the CURE® Educated Patient® Lung Cancer Summit.

May 09, 2023

The benefit derived from Tyvyt plus chemotherapy was present regardless of whether previously treated patients with EGFR-mutated, non-squamous non-small cell lung cancer also received Byvasda.

May 09, 2023

Patients with advanced or recurrent endometrial cancer derived a survival benefit from Jemperli plus chemotherapy.

May 08, 2023

Patients with advanced or recurrent endometrial cancer treated with Keytruda plus chemotherapy had improved progression-free survival compared with chemotherapy alone.

May 04, 2023

Findings from a study demonstrated that patients may develop hypertension, or high blood pressure, as a result of treatment with Imbruvica for CLL, although it may be quickly managed without drug-drug interactions.

April 27, 2023

CURE® welcomed over 500 attendees in person and hundreds virtually during the hybrid Extraordinary Healer® event.

April 25, 2023

Watch Dr. Marc Braunstein, from NYU Langone Hospital, discuss the role of bone marrow transplant during the CURE Educated Patient Multiple Myeloma Summit.

April 24, 2023

Watch Dr. Dickran Kazandjian, from Miami Health System, discuss updates in newly diagnosed disease during the CURE Educated Patient Multiple Myeloma Summit.

April 21, 2023

A patient with head and neck cancer highlights the importance of a strong support system throughout the time he was recovering from surgery.

April 18, 2023

One patient was able to access a therapy for follicular lymphoma before it was approved by the FDA, which allowed him to help future patients through his experience.

April 17, 2023

The inflammation associated with lung cancer and depression may impact survival, despite treatments like immunotherapy and targeted therapies.

April 14, 2023

After being given 2 years to live by her oncologist, a mother of two children is trying her best to protect her family — and herself — from thinking too negatively despite having rare gastrointestinal cancer.

April 13, 2023

If approved by the FDA, Keytruda plus chemotherapy could provide a frontline therapy for patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.

April 13, 2023

For some patients with non-small cell lung cancer, removing part of the lobe rather than the entire lobe still provides benefit, study results show.

April 12, 2023

Researchers conducting the VISTA-101 study will assess the safety and efficacy of KVA12123 alone and with Keytruda, in addition to determining the recommended dose of the therapy.